Aykul et al. and Lees-Shepard et al. independently found that antibodies against ACVR1, which were being developed as potential therapeutics for FOP, instead caused HO in FOP mice. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.